Explore our solutions

Target area
Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.
Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.
- Biologics screening and characterization: Explore assays for biologics screening, mechanism-of-action studies, and biomanufacturing.
- Biomarker detection: Accurate detection and quantitation of molecular targets across serum, plasma, culture supernatants, cellular lysates, and other sample types.
- Cell and gene therapy: Discover and advance cell and gene therapy research with bioanalytical immunoassays for CGT development.
- Cell signaling: Focus on cell signaling and intracellular phosphorylated proteins, with streamlined approaches to pathway analysis.
- Cytokines: Access a comprehensive range of cytokine assay kits, including interleukins, interferons, chemokines, tumor necrosis factors, and lymphokines.
- Epigenetics: Leverage our epigenetics toolbox, designed to detect specific methylation and acetylation marks on histone peptide substrates.
- GPCRs: Measure cAMP levels and track downstream protein phosphorylation with functional GPCR assays.
- Protein kinases: Explore an extensive portfolio of protein phosphorylation assays, available in cell-based or biochemical no-wash formats.
- Protein-protein interactions: Utilize highly sensitive assays to study protein interactions involved in a range of biological processes.
- Receptor binding: Access cell-based solutions with no separation steps and eliminate radioactive waste, an improvement over traditional SPA and radioligand binding assays.
- Targeted protein degradation: Monitor protein expression levels and characterize the mechanism of action using our total and phospho kits.

Therapeutic area
Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.
Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.
- Autoimmune diseases: Comprehensive reagents for autoimmune disease research, including rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, and more.
- Obesity, diabetes, and metabolic diseases: Solutions for drug discovery in obesity, diabetes, and metabolic diseases, featuring assays for biomarker detection, protein analysis, and GPCR research.
- Fibrosis: Ready-to-use assays for monitoring biomarkers, phosphoproteins, and transcription factors relevant to fibrotic disease research.
- Immuno-oncology: Assays for studying immunity and immune cells, covering protein, biomarker, and cytokine detection, as well as cell toxicity and proliferation.
- Oncology: A comprehensive oncology portfolio, including assays for cytokines, biomarkers, phospho-proteins, cell proliferation, cytotoxicity, and more.
- Neuroscience: A wide range of neuroscience assays to support research in neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington's disease.
- Virology: Assay technologies for viral studies, enabling assessment of viral life cycles and antiviral immune responses with streamlined workflows.
Featured resources


Filters
1 - 25 of 1235 Products and Services
This HTRF kit allows for the cell-based quantitative detection of DAP12 when phosphorylated at Tyr91.
This HTRF kit allows for the cell-based quantitative detection of Total Tie2.
This HTRF kit allows for the cell-based quantitative detection of Tie2 when phosphorylated at Tyr992.
This HTRF kit allows for the cell-based quantitative detection of Total PARP1.
This HTRF kit allows for the cell-based quantitative detection of Total IRE1.
This HTRF kit allows for the cell-based quantitative detection of IRE1 when phosphorylated at Ser724.
This HTRF kit allows for the cell-based quantitative detection of total ARID1A.
This HTRF kit allows for the cell-based quantitative detection of total DAP12.
This HTRF kit allows for the cell-based quantitative detection of IRAK4 when phosphorylated at Thr345.
This HTRF kit allows for the cell-based quantitative detection of Total YES.
This HTRF kit allows for the cell-based quantitative detection of NPM1 when phosphorylated at Thr199.
This HTRF kit allows for enable the cell-based quantitative detection of Total SALL4.
This HTRF kit allows for the cell-based quantitative detection of MerTK when phosphorylated at Tyr749.
This HTRF kit allows for the cell-based quantitative detection of Total HSP27.
The HTRF Human Androgen Receptor Variant 7 kit is designed to quantify the expression levels of Androgen Receptor variant 7 (AR-V7) within cell lysates.
The HTRF Human and Mouse Ataxin 2 Detection Kit is designed for the quantitative measurement of Ataxin 2 in human and mouse cell lysates.
The Total IKK-alpha kit monitors the cellular IKK-alpha expression level and can be used as a normalization assay for the phospho-IKK-alpha kit.
The Total EGFR L858R kit is designed to quantify the expression level of EGFR mutant L858R in cells.
This HTRF kit detects cellular STAT1 and can be used as a normalization assay with our phospho-STAT1 kit for an optimal readout of JAK/STAT signaling.
The phospho-HER3 (Tyr1289) kit enables the cell-based detection of human epidermoid growth factor 3 (HR3, Erbb3) signaling activity when phosphorylated on Tyr1289
The total p53 kit detects cellular p53 and can be used as a normalization assay for the phospho-p53 kit. It is optimal for monitoring cellular response to DNA damage.
This HTRF kit enables the cell-based quantitative detection of CHK1 phosphorylation at Ser345, which is activated upon DNA damage. This kit enables optimal investigation of the ATR/CHK1 pathway, such as via its selective inhibitors.
The phospho-TBK1 (Ser172) assay enables the cell-based quantitative detection of phosphorylated TBK1 on Ser172 as a readout of the TLR3/4, cGAS-STING pathways
This HTRF kit enables the cell-based detection of phosphorylated TAU at Serine 422, as a marker of neurodegenerative diseases.
This HTRF kit enables the cell-based quantitative detection of phosphorylated Rb as a readout of the G0/G1 cell phase transition.